Mercer Global Advisors
FBT icon

Mercer Global Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Mercer Global Advisors’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.91M Buy
+19,486
New +$4.03M 0.01% 870
2024
Q1 		– Sell
-1,356
Closed -$214K – 2064
2023
Q4 		$214K Buy
+1,356
New +$195K ﹤0.01% 1799

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Mercer Global Advisors's FBT Position: Q1 2026 in Review

Mercer Global Advisors opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2026: 19,486 shares worth $3.91M. The stake represents 0.01% of the portfolio and ranks #870 among its holdings. This is a return to the name: Mercer Global Advisors previously reported a position in FBT as recently as Q4 2023.

Mercer Global Advisors first reported a position in FBT in Q4 2023 and has held it in 2 quarters since. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Mercer Global Advisors held 19,486 shares of First Trust NYSE Arca Biotechnology Index Fund worth $3.91M as of Q1 2026.
  • First Trust NYSE Arca Biotechnology Index Fund was a new Mercer Global Advisors position in Q1 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of Mercer Global Advisors's portfolio in Q1 2026, its #870 holding.
  • Mercer Global Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2023 and has held it in 2 quarters since.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.